Advancing Research to Treatments (ART) Presenter Publications

Charles Conrad, MD
University of Texas MD Anderson Cancer Center

Growth Factor Signaling in Cell Survival: Implications for Cancer Treatment

IMPROVING CANCER RADIOTHERAPY WITH 2-DEOXY-D-GLUCOSE: PHASE I/II CLINICAL TRIALS ON HUMAN CEREBRAL GLIOMAS

2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/AMP-activated protein kinase signaling activation or glycolysis inhibition

Lawrence Lamb, Jr., PhD
University of Alabama at Birmingham

Preclinical evaluation of ex vivo expanded/activated cd T cells for immunotherapy of glioblastoma multiforme

T Cells: A New Frontier for Immunotherapy?

Glioma Cells Display Complex Surface Topographies That Resist the Actions of Cytolytic Effector Lymphocytes

Engineered Drug Resistant T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy

John Sampson, MD, PhD
Duke University

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Bispecific antibodies engageT cells for antitumor immunotherapy